Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04988490 · ClinicalTrials.gov registry record
Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 68
- Enrollment target
NCT04988490: Completed study, sponsored by University of Colorado, Denver.
NCT04988490 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04988490 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
To determine how daily cannabis use affects surgical outcomes.
Primary Outcome
Postoperative opioid consumption among daily cannabis using and non-cannabis using patients undergoing abdominal surgery for cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2024-06-14 |
What the finished NCT04988490 record still lists
NCT04988490 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04988490 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04988490 about?
NCT04988490 is a clinical study titled "Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes". To determine how daily cannabis use affects surgical outcomes.
What is the current status of trial NCT04988490?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2021-10-11. Estimated completion is 2024-06-14.
Who is sponsoring clinical trial NCT04988490?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI